Background: Little non-clinic-based data are available on incident genital warts rates and
related healthcare use. Goal: The goal of this study was to describe the incidence and …

Objective: This study examined the incidence of and healthcare costs attributable to genital
warts within a large US commercially insured, geographically dispersed population …

We estimated the prevalence of and costs associated with genital warts among privately
insured individuals from the perspective of a private health plan in the United States. Health …

OBJECTIVE: Worldwide, genital warts, caused by human papillomavirus (HPV) is a
common, sexually transmitted disease. The overall disease management strategy for genital …

Background: Genital warts are caused by human papillomavirus (HPV); over 90% are due to
HPV types 6 and 11. We determined the percentage of persons who reported having been …

Background: Genital warts (condyloma acuminatum) remain one of the most commonly
reported sexually transmitted infections (STI) worldwide. Most genital warts are caused by …

Objectives. We estimated anogenital wart prevalence from 2003 to 2010 by gender and age
group in a large US cohort with private insurance to detect potential decreases among …

Background This study estimated genital warts prevalence, genital-warts-related healthcare
resource use and costs, and self-reported human-papillomavirus-related psychosocial …

Background Human papillomavirus (HPV) is a necessary cause of cervical cancer. HPV is
also responsible for benign condylomata acuminata, also known as genital warts. We …

Objectives To estimate the loss of quality of life and cost of treatment associated with genital
warts seen in sexual health clinics. Methods A cross-sectional questionnaire study and case …